Press release Biocartis Group: BIOCARTIS ANNOUNCES RESIGNATION CFO

Ads

You May Also Like

Epizyme Announces Date of First Quarter 2017 Financial Results and Tazemetostat Data Presentations at ASCO

CAMBRIDGE, Mass., April 20, 2017 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical ...

Heat Biologics Reports Fiscal Year 2016 Financial Results

DURHAM, N.C., March 31, 2017 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (Nasdaq:HTBX), a ...